Pfizer-Backed VitaDAO Votes on Creating For-Profit Company to Fund Longevity Research
Join the most important conversation in crypto and Web3 taking place in Austin, Texas, April 26-28.
:format(jpg)/s3.amazonaws.com/arc-authors/coindesk/dcfcc5f4-a693-418d-a529-bb8e772f39d1.png)
Elizabeth Napolitano is a news reporter at CoinDesk.
Join the most important conversation in crypto and Web3 taking place in Austin, Texas, April 26-28.
Members of Pfizer-backed VitaDAO are voting on whether to create a for-profit company to secure and distribute funding for longevity research, the collective tweeted on Wednesday.
The company, to be called VitaTech, would leverage public funding to license longevity technologies developed in U.S. universities and support their continued development. The funds would come from research foundations and government grants such as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR).
“To make up for [VitaDAO’s funding] shortfall, we are currently discussing a proposal to establish a for-profit US-based company that will bridge the gap between research and commercialization,” the collective tweeted.
The company will operate as a subsidiary or affiliate of VitaDAO. It also aims to serve as a launchpad for startups, helping research grant holders commercialize their tech, according to the proposal.
The proposal will enter a 10-week execution phase between April 3 and June 12, 2023, if approved.
VitaDAO raised $4.1 million in a funding round led by Pfizer Ventures with participation from several other investors in January. Pfizer is the first pharmaceutical company to weigh in on decentralized autonomous organization proposals and participate in the VitaDAO project’s incubation and commercialization.
VITA inched up 3% in the past 24 hours, according to CoinDesk data.
Edited by James Rubin.
DISCLOSURE
Please note that our
privacy policy,
terms of use,
cookies,
and
do not sell my personal information
has been updated
.
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a
strict set of editorial policies.
CoinDesk is an independent operating subsidiary of
Digital Currency Group,
which invests in
cryptocurrencies
and blockchain
startups.
As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of
stock appreciation rights,
which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG
.
Elizabeth Napolitano is a news reporter at CoinDesk.
Learn more about Consensus 2023, CoinDesk’s longest-running and most influential event that brings together all sides of crypto, blockchain and Web3. Head to consensus.coindesk.com to register and buy your pass now.
Elizabeth Napolitano is a news reporter at CoinDesk.
